90 related articles for article (PubMed ID: 16108616)
1. [Action of EM703 on bleomycin-induced pulmonary fibrosis in mice].
Li ; Matsuda K; Aoyama S; Shirokine J; Azuma A; Kudo S; Sunazuka T; Omura T
Jpn J Antibiot; 2004 Jun; 57 Suppl A():129-33. PubMed ID: 16108616
[No Abstract] [Full Text] [Related]
2. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
3. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
4. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR
Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624
[TBL] [Abstract][Full Text] [Related]
5. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
Hu P; Gao ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
Hagiwara SI; Ishii Y; Kitamura S
Am J Respir Crit Care Med; 2000 Jul; 162(1):225-31. PubMed ID: 10903246
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
8. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
9. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.
Nagao S; Taguchi K; Sakai H; Tanaka R; Horinouchi H; Watanabe H; Kobayashi K; Otagiri M; Maruyama T
Biomaterials; 2014 Aug; 35(24):6553-62. PubMed ID: 24811261
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on effect of Huaxian Decoction treating bleomycin-induced pulmonary fibrosis in mice].
Wang SJ; Bai W; Wang CL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):347-51. PubMed ID: 17526177
[TBL] [Abstract][Full Text] [Related]
12. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis.
Matsuoka H; Arai T; Mori M; Goya S; Kida H; Morishita H; Fujiwara H; Tachibana I; Osaki T; Hayashi S
Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L103-12. PubMed ID: 12060566
[TBL] [Abstract][Full Text] [Related]
13. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
Giri SN; Hyde DM
Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
[TBL] [Abstract][Full Text] [Related]
14. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
15. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
[TBL] [Abstract][Full Text] [Related]
18. The role of collagenases in experimental pulmonary fibrosis.
Ouchi H; Fujita M; Ikegame S; Ye Q; Inoshima I; Harada E; Kuwano K; Nakanishi Y
Pulm Pharmacol Ther; 2008; 21(2):401-8. PubMed ID: 18060817
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice.
Tamagawa K; Taooka Y; Maeda A; Hiyama K; Ishioka S; Yamakido M
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1279-84. PubMed ID: 10764324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
